Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2026-03-08 @ 11:22 PM
Study NCT ID:
NCT02575833
Status:
COMPLETED
Last Update Posted:
2018-08-24
First Post:
2015-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treadmill Cardiovascular Safety Study of Erenumab (AMG 334)
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-07
First Submit QC Date:
None
Study First Post Date:
2015-10-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-21
Results First Submit QC Date:
None
Results First Post Date:
2018-07-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-11-14
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-07-27
Last Update Post Date:
2018-08-24
Last Update Post Date Type:
ACTUAL